CH558374A - Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten. - Google Patents

Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.

Info

Publication number
CH558374A
CH558374A CH450074A CH450074A CH558374A CH 558374 A CH558374 A CH 558374A CH 450074 A CH450074 A CH 450074A CH 450074 A CH450074 A CH 450074A CH 558374 A CH558374 A CH 558374A
Authority
CH
Switzerland
Prior art keywords
chinazolone
alkenyl
aryl
derivatives
production
Prior art date
Application number
CH450074A
Other languages
German (de)
English (en)
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CH558374A publication Critical patent/CH558374A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH450074A 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten. CH558374A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702027645 DE2027645A1 (de) 1970-06-05 1970-06-05 Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH558374A true CH558374A (de) 1975-01-31

Family

ID=5773104

Family Applications (3)

Application Number Title Priority Date Filing Date
CH450174A CH569732A5 (fr) 1970-06-05 1971-06-02
CH802071A CH557829A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.
CH450074A CH558374A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CH450174A CH569732A5 (fr) 1970-06-05 1971-06-02
CH802071A CH557829A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.

Country Status (10)

Country Link
US (1) US3984555A (fr)
AT (3) AT317899B (fr)
BE (1) BE768137A (fr)
CA (1) CA951319A (fr)
CH (3) CH569732A5 (fr)
DE (1) DE2027645A1 (fr)
FR (1) FR2100726B1 (fr)
GB (1) GB1331522A (fr)
LU (1) LU63267A1 (fr)
NL (1) NL7107695A (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US6723727B1 (en) * 1996-12-20 2004-04-20 Hoechst Aktiengesellschaft Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
US5972929A (en) * 1997-08-21 1999-10-26 Shiseido Co., Ltd. Quinazolinone derivative, hair growth promoter and external composition for skin using the same
AU7734700A (en) 1999-10-01 2001-05-10 Advanced Medicine, Inc. Macrocyclic quinazolinones and their use as local anesthetics
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
PT1939203E (pt) * 2000-04-25 2015-02-04 Icos Corp Inibidores da isoforma delta da fosfatidil-inositol 3-quinase humana
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
ATE469648T1 (de) 2001-09-05 2010-06-15 Minerva Biotechnologies Corp Zusammensetzungen und deren verwendung zur behandlung von krebs
JP2005501887A (ja) * 2001-09-05 2005-01-20 ミナーヴァ・バイオテクノロジーズ・コーポレーション 癌の処置における組成物およびその使用
US7060705B2 (en) 2001-11-07 2006-06-13 Merck & Co., Inc. Mitotic kinesin inhibitors
AUPS019702A0 (en) * 2002-01-29 2002-02-21 Fujisawa Pharmaceutical Co., Ltd. Condensed heterocyclic compounds
EP1539180A4 (fr) * 2002-08-21 2006-08-30 Cytokinetics Inc Composes, compositions et methodes
WO2004041755A2 (fr) * 2002-11-04 2004-05-21 Nps Pharmaceuticals, Inc. Composes de quinazolinone utilises comme calcilytiques
EP1646615B1 (fr) * 2003-06-06 2009-08-26 Vertex Pharmaceuticals Incorporated Derives de pyrimidne utilises en tant que modulateurs de transporteurs de cassette de liaison a l'atp
WO2005016349A1 (fr) * 2003-08-14 2005-02-24 Icos Corporation Methodes d'inhibition de l'accumulation des leucocytes
WO2005016348A1 (fr) * 2003-08-14 2005-02-24 Icos Corporation Methodes d'inhibition de reponses immunes stimulees par un facteur endogene
ES2605792T3 (es) * 2004-05-13 2017-03-16 Icos Corporation Quinazolinona usada como inhibidor de la fosfatidilinositol 3-quinasa delta humana
EP1755609A1 (fr) * 2004-05-25 2007-02-28 Icos Corporation Methodes de traitement et/ou de prevention de la proliferation aberrante des cellules hematopoietiques
AU2006214190A1 (en) * 2005-02-17 2006-08-24 Icos Corporation Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
CA2914168C (fr) 2006-03-28 2018-05-08 Atir Holding S.A. Derives de pyrido[1,2-a]pyrimidin-4-one et leur utilisation pour le traitement de troubles sexuels
CN104042618B (zh) 2008-11-13 2018-02-16 吉利德卡利斯托加公司 恶性血液病的治疗
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
AU2010229968A1 (en) 2009-03-24 2011-10-13 Gilead Calistoga Llc Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
EA201101507A1 (ru) * 2009-04-20 2012-05-30 Гилеад Калистога Ллс. Способы лечения солидных опухолей
EP2456443A1 (fr) 2009-07-21 2012-05-30 Gilead Calistoga LLC Traitement de troubles du foie par des inhibiteurs de pi3k
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
EP3581567A1 (fr) * 2011-04-10 2019-12-18 Atir Holding S.A. Composés hétérocycliques et leurs utilisations dans le traitement de troubles sexuels
EA201691327A1 (ru) 2012-03-05 2017-03-31 Джилид Калистога Ллс Полиморфные формы (s)-2-(1-(9h-пурин-6-иламино)пропил)-5-фтор-3-фенилхиназолин-4(3h)-она
EP2870140B8 (fr) 2012-07-09 2016-09-28 Lupin Limited Derives de tetrahydroquinazolinone comme inhibiteurs de parp
EP3083623A1 (fr) 2013-12-20 2016-10-26 Gilead Calistoga LLC Formes polymorphes d'un sel chlorhydrate de la (s)-2-(9h-purine-6-ylamino)propyl)-5-fluoro-3-phénylquinazolin-4(3h)-one
NZ736970A (en) 2013-12-20 2018-11-30 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
AU2015274696B2 (en) 2014-06-13 2018-09-27 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053063A (fr) * 1963-05-18

Also Published As

Publication number Publication date
US3984555A (en) 1976-10-05
DE2027645A1 (de) 1971-12-09
AT317899B (de) 1974-09-25
CH569732A5 (fr) 1975-11-28
LU63267A1 (fr) 1972-08-23
NL7107695A (fr) 1971-12-07
CH557829A (de) 1975-01-15
CA951319A (en) 1974-07-16
AT318615B (de) 1974-11-11
FR2100726B1 (fr) 1975-10-10
BE768137A (fr) 1971-12-06
AT318628B (de) 1974-11-11
FR2100726A1 (fr) 1972-03-24
GB1331522A (en) 1973-09-26

Similar Documents

Publication Publication Date Title
CH558374A (de) Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.
CH552608A (de) Verfahren zur herstellung von azaspiroalkandion-derivaten.
AT289065B (de) Verfahren zur Herstellung von 2,3,6-Trimethylphenol
CH547290A (de) Verfahren zur herstellung von nitro-imidazolderivaten.
CH557823A (de) Verfahren zur herstellung von piperazinderivaten.
CH550771A (de) Verfahren zur herstellung von phenaethylaminderivaten.
CH558353A (de) Verfahren zur herstellung von isoindolinderivaten.
CH550186A (de) Verfahren zur herstellung von 5-imino-1.2.4-triazin-derivaten.
CH550133A (de) Verfahren zur herstellung von 4-methyl-pentanol-2-crotonat.
CH555801A (de) Verfahren zur herstellung von phenylaethanolamin-derivaten.
CH550797A (de) Verfahren zur herstellung von tetrahydroisochinolinderivaten.
CH551984A (de) Verfahren zur herstellung von piperazinderivaten.
CH550214A (de) Verfahren zur herstellung von cyclocopolymerisaten.
CH553185A (de) Verfahren zur herstellung von lumilysergol-derivaten.
CH549567A (de) Verfahren zur herstellung von 8-cyano-5-octanolid.
CH547775A (de) Verfahren zur herstellung von diaethylaminopropionaniliden.
CH558800A (de) Verfahren zur herstellung von chinazolinonen.
CH557830A (de) Verfahren zur herstellung von 1-aminosiochinolinen.
CH547802A (de) Verfahren zur herstellung von tetrahydropyridinderivaten.
CH555314A (de) Verfahren zur herstellung von cyclopropylmethylalkylaminen.
CH546782A (de) Verfahren zur herstellung von oxadiazolderivaten.
CH557801A (de) Verfahren zur herstellung von 1,1,3-trialkoxy-2-cyanopropanen.
CH537891A (de) Verfahren zur Herstellung von 2,3,6-Trimethylphenol
CH547771A (de) Verfahren zur herstellung von bornanaminderivaten.
CH550809A (de) Verfahren zur herstellung von triazol-derivaten.

Legal Events

Date Code Title Description
PL Patent ceased